Results 81 to 90 of about 6,424,268 (248)

Synthesis and Characterization of FeІІ , CoІІ , NiІІ , CuІІ and ZnІІ Complexes With Dithiocarbamate and N-Donor Ligands

open access: yesIbn Al-Haitham Journal for Pure and Applied Sciences, 2017
New complexes of first series of transition metals with P-amino benzene dithiocarbamate of the general formula [M(PABdtc)2] and [ M(PABdtc)2(L)n] M=Fe( ІІ ),Co( ІІ ),Ni( ІІ ) ,Cu(ІІ) and Zn (ІІ). PABdtc = Paraamino benzene dithiocarbamate ,n=2
Mohammed Jassim Mohammed   +1 more
doaj   +1 more source

Reconstructing enzyme evolution by protein engineering

open access: yesFEBS Letters, EarlyView.
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler   +2 more
wiley   +1 more source

Проценка на ризик за безбедноÑта на водата за пиење и водоÑнабдувањето во КичевÑкиот регион за периодот од 1996-2013 година

open access: yes, 2017
Intensification of systemic chemotherapy with in- clusion of high doses methotrexate (MTX) has contributed to the improvement of event-free survival in children with acute lymphoblastic leukemia (ALL). Despite this benefit, this agent might cause serious
ЕфтимијадоÑка (Eftimijadoska), Фани (Fani)
core  

Supermembranes and domain walls in N $$ \mathcal{N} $$ = 1, D = 4 SYM

open access: yesJournal of High Energy Physics, 2019
We construct a manifestly supersymmetric and kappa-symmetry invariant worldvolume action describing the coupling of a dynamical membrane to an N $$ \mathcal{N} $$ = 1, D = 4 SU(N ) super-Yang-Mills multiplet.
Igor Bandos   +2 more
doaj   +1 more source

Identification of a Shiga toxin A‐derived peptide internalized into Gb3 receptor‐bearing cells via interaction with the Shiga toxin B subunit

open access: yesFEBS Letters, EarlyView.
The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi   +6 more
wiley   +1 more source

Бихејвиор терапија во третманот на фобично-анкÑиозни ÑоÑтојби

open access: yes, 2017
It has been described the use of systematic desensitisation in the treatment of monosymptomatic phobias. The technique of suggestion with medicaments was used.
Петров (Petrov), Златко (Zlatko)   +2 more
core  

Tagelda n Kuku d tqerrabin d lǧerrat tinmettiyin i d-teǧǧa

open access: yesRevue d'Histoire Méditerranéenne
Deg umagrad-a, nemmeslay-d ɣef yiwet n tgelda i yesɛan azal meqqren deg umezruy atrar n Lezzayer s umata ladɣa amezruy n tmurt n Leqbayel, tagi d tageda n Kuku i d-ibanen deg useggas 1511, seld tuṭṭfa n temdint n Bgayet s ɣur Spenyul deg useggas 1510 ...
BENCHIKHE Ali
doaj  

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

open access: yesMolecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce   +11 more
wiley   +1 more source

Целена пÑиходинамÑка пÑихотерапија во лекувањето на неврозата

open access: yes, 2016
The patients were treated with the method of psychoanalysis. They represented symptoms of the convertible fobicle neurosis. The author was an observer of the therapy, and at the same time, he was an object of the supervision of psychotherapist.
Мицев (Micev), Миодраг (Miodrag)   +1 more
core  

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy